Improved ELISPOT protocol for monitoring Th1/Th17 T-cell response following T.gondii infection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38718078.
- Also identified by DOI 10.1371/journal.pone.0301687 and PMC identifier 11078343.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the monitoring of human Toxoplasma gondii infection, it is crucial to confirm the development of a specific Th1/Th17 immune response memory. The use of a simple, specific, and sensitive assay to follow the T-cell activation is thus required. Current protocols are not always specific as stimulation with peptides is Human Leukocyte Antigen (HLA)-dependent, while stimulation with total-lysis antigens tends to stimulate seronegative donors resulting to false positives. Here, an improved ELISPOT protocol is reported, using peripheral blood mononuclear cells (PBMC) of T.gondii-infected donors, incubated with the inactivated parasite. The results showed that, contrary to standard protocols, a pre-incubation step at high cell density in presence of the inactivated parasite allowed a specific Th1/Th17 response with the secretion of IFN-γ, IL-2, IL-12 and IL-17 cytokines. This protocol allows to evaluate precisely the immune response after a T.gondii infection.
Medical subject headings
- Th1 Cells
- Th17 Cells
- Enzyme-Linked Immunospot Assay
- Toxoplasmosis
- Toxoplasma